Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › bosutinib

bosutinib

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of bosutinib

13 trials tracked of bosutinib: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 491 citations.

13Trials tracked
3Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 3 Phase 2 5 Phase 1 2 Other / NA 3
  1. Phase 3 A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia Completed · 491 cited
  2. Phase 3 Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs Completed · 332 cited
  3. Phase 3 Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML Completed
  4. Phase 2 Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias Completed
  5. Phase 2 Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML Completed
  6. Phase 2 Bosutinib in Adult Patients With Recurrent Glioblastoma Completed
Show 7 more trials
  1. Phase 2 Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia Completed
  2. Phase 2 Bosutinib For Autosomal Dominant Polycystic Kidney Disease Completed
  3. Phase 1 Evaluation of the Relative Bioavailability of Bosutinib Capsules Under Fed Condition and Estimation of Food Effect on Orally Administered Bosutinib Capsule Completed
  4. Phase 1 Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors Completed
  5. N/A Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008 Completed
  6. N/A A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands Completed
  7. N/A Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Case report on asciminib plus ponatinib or axitinib in CML relapse with B lymphoblastic blast crisis
Oncology
Case report on asciminib plus ponatinib or axitinib in CML relapse with B lymphoblastic blast crisis New combo drug stops leukemia that fought back against two drugs
This case report describes a single CML patient who relapsed with B lymphoblastic blast crisis harboring a T315I mutation and a novel e6a3 B…
A new three-drug mix stops a tough leukemia that grew stronger after two drugs failed to control it.
medRxiv Apr 24, 2026